Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials

Newly diagnosed multiple myeloma (NDMM) patients treated with immunomodulatory drugs are at high risk of venous thromboembolism (VTE), but data are lacking from large prospective cohorts. We present thrombosis outcome data from Myeloma IX (n = 1936) and Myeloma XI (n = 4358) phase 3 randomized contr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Bradbury, Charlotte A., Craig, Zoe, Cook, Gordon, Pawlyn, Charlotte, Cairns, David A., Hockaday, Anna, Paterson, Andrea, Jenner, Matthew W., Jones, John R., Drayson, Mark T., Owen, Roger G., Kaiser, Martin F., Gregory, Walter M., Davies, Faith E., Child, J. Anthony, Morgan, Gareth J., Jackson, Graham H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Thrombosis and Hemostasis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7453153/
https://ncbi.nlm.nih.gov/pubmed/32438407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020005125
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados